tiprankstipranks
Trending News
More News >
EGF Theramed Health (TSE:TMED)
:TMED

EGF Theramed Health (TMED) Price & Analysis

Compare
6 Followers

TMED Stock Chart & Stats

C$0.07
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.07
C$0.00(0.00%)

Bulls Say, Bears Say

Bulls Say
Operating Cash Flow Turned Slightly PositiveA move to positive operating and free cash flow in 2025 indicates the company generated cash from operations after several years of outflows. If sustained, even small positive cash generation reduces near-term financing pressure, demonstrating improving operational cash discipline and offering a foundation to stabilize liquidity over the medium term.
Historical Reduction In Net LossesThe material reduction in annual losses after 2020 shows the company has previously been able to compress expenses or rebase operations. This historical improvement suggests management capability to cut burn and restructure operations, a durable operational competency that could support a path to sustainability if maintained and scaled.
Industry Exposure: Healthcare Information ServicesOperating in healthcare information services places the company in a structurally growing sector driven by digitalization, electronic health records, and data analytics demand. Such secular tailwinds can expand the addressable market and support recurring revenue models, providing long-term commercial opportunities if the company can commercialize offerings.
Bears Say
No Reported RevenueThe absence of reported revenue across all years is a fundamental red flag: it implies no validated product-market fit or monetization to support operations. Without revenue, the business must rely on external financing, which is not a durable model and elevates execution and survivability risk over the medium term.
Negative Equity And Very Weak Balance SheetNegative shareholders' equity and a tiny asset base versus meaningful debt create acute solvency and recapitalization risk. This structural weakness limits financial flexibility, increases dilution likelihood, and constrains the company's ability to invest in growth or withstand shocks, undermining long-term viability without substantial recapitalization.
Persistent Negative Operating ResultsSustained negative EBIT and EBITDA indicate the core business has not reached profitability nor demonstrated margin sustainability. Combined with only a small recent cash flow uptick, persistent operating losses suggest ongoing funding needs and a structural challenge to achieve durable margins without meaningful business model progress or cost transformation.

TMED FAQ

What was EGF Theramed Health’s price range in the past 12 months?
EGF Theramed Health lowest stock price was C$0.06 and its highest was C$0.13 in the past 12 months.
    What is EGF Theramed Health’s market cap?
    EGF Theramed Health’s market cap is C$929.33K.
      When is EGF Theramed Health’s upcoming earnings report date?
      EGF Theramed Health’s upcoming earnings report date is Jun 02, 2026 which is in 74 days.
        How were EGF Theramed Health’s earnings last quarter?
        EGF Theramed Health released its earnings results on Feb 24, 2026. The company reported -C$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.006.
          Is EGF Theramed Health overvalued?
          According to Wall Street analysts EGF Theramed Health’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does EGF Theramed Health pay dividends?
            EGF Theramed Health does not currently pay dividends.
            What is EGF Theramed Health’s EPS estimate?
            EGF Theramed Health’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does EGF Theramed Health have?
            EGF Theramed Health has 11,616,665 shares outstanding.
              What happened to EGF Theramed Health’s price movement after its last earnings report?
              EGF Theramed Health reported an EPS of -C$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of EGF Theramed Health?
                Currently, no hedge funds are holding shares in TSE:TMED
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  Company Description

                  EGF Theramed Health

                  EGF Theramed Health Corp. provides psychedelic drugs for the treatment of mental health. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression. The company was incorporated in 2011 and is headquartered in Vancouver, Canada.

                  EGF Theramed Health (TMED) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  nDatalyze Corp
                  TripSitter Clinic Ltd
                  PanGenomic Health, Inc. Class A
                  DiagnaMed Holdings Corp.
                  Popular Stocks